Pharmafile Logo
Pharmafocus logo
Advanced Search

cemiplimab

Showing 1 posts of 1 posts found.

sanofi_hq__boetie_hall_web

Sanofi’s Libtayo shows positive Phase III results in advanced cervical cancer

May 13, 2021
Libtayo, Sanofi, cemiplimab, cervical cancer

Regeneron Pharmaceuticals and Sanofi have announced today positive Phase III trial results investigating the PD-1 inhibitor Libtayo (cemiplimab) in patients …

News

Latest content

Ardena announces €20m expansion following first GMP approval

April 19, 2024

Roche’s Alecensa approved by FDA as lung cancer treatment

April 19, 2024

GSK shares results from phase 3 trial for gonorrhoea treatment

April 18, 2024

Eli Lilly’s tirzepatide demonstrates efficacy in reducing sleep apnoea severity

April 18, 2024

Medincell and AbbVie enter agreement for development of next-generation injectables

April 17, 2024